Lords Mark Biotech Private Limited, a active private limited company, was established on 10 November 2022 in Mumbai, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U24290MH2022PTC393233. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
Employing 196 professional, Its leadership includes Anurag Kar (Additional Director), Dharmendra Navin Sinha (Additional Director). Past directors included Sachidanand Hariram Upadhyay, Manav Kishore Teli. It holds ₹16.30 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B 101 Ridhi Sidhi Complex M.G Road Borivali East Mumbai, Mumbai, Maharashtra, 400066.
U24290MH2022PTC393233
393233
10 November 2022
₹5.00 Cr
₹5.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lords Mark Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anurag Kar | Additional Director | 17 Mar 2025 | Current |
| Dharmendra Navin Sinha | Additional Director | 17 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Apr 2025 | Past |
| Pramod Abcsdd | Director | 12 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lords Mark Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Lords Mark Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹163,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Canara Bank | ₹3.00 Cr | Open |
| 23 Mar 2023 | Others | ₹13.30 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lords Mark Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lords Mark Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lords Mark Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anurag Kar was appointed as a Additional Director was appointed as a Additional Director on 17 Mar 2025 & has been associated with this company since 8 months 12 days . was completed.
Progress on Dharmendra Navin Sinha was appointed as a Additional Director was appointed as a Additional Director on 17 Mar 2025 & has been associated with this company since 8 months 12 days . was documented.
Progress on Lords Mark Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Lords Mark Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge with Canara Bank amounted to Rs. 3.00 Cr with Charge ID 100840412 was registered on 30 Sep 2023. was recorded as a recent event.
A charge with Others amounted to Rs. 13.30 Cr with Charge ID 100692252 was registered on 23 Mar 2023. was recorded as a recent event.
The CIN of Lords Mark Biotech Private Limited is U24290MH2022PTC393233.
Lords Mark Biotech Private Limited is headquartered at B 101 Ridhi Sidhi Complex M.G Road Borivali East Mumbai, Mumbai, Maharashtra, 400066.
Lords Mark Biotech Private Limited was incorporated on 10 November 2022.
The current directors of Lords Mark Biotech Private Limited are
The primary industry of Lords Mark Biotech Private Limited is Healthcare.
Lords Mark Biotech Private Limited is unlisted.
The authorized capital of Lords Mark Biotech Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX